Ocugen, Inc. (OCGN)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 1.7200 |
| Open | 1.7000 |
| Bid | 1.4200 x 100 |
| Ask | 1.6800 x 4200 |
| Day's range | 1.6150 - 1.7150 |
| 52-week range | 0.3450 - 2.1050 |
| Volume | |
| Avg. volume | 10,286,550 |
| Market cap | 429.738M |
| Beta (5Y monthly) | 3.80 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards?
Ocugen (OCGN) is expected to provide updates regarding the developmental program of its lead candidate, OCU400, for two rare retinal diseases in the first-quarter earnings release.
- Zacks
Ocugen (OCGN) Up as DSMB Allows Cohort 2 Dosing in GA Study
Ocugen (OCGN) stock gains as the DSMB for the phase I/II study of OCU410 approves the initiation of dosing with the medium dose of OCU410 in the dose-escalation phase of the GA study.
© 2024 Yahoo. All rights reserved.